Geir E. Tjønnfjord, MD, PhD

Department of Haematology, Oslo University Hospital
Oslo, Norway

N/A

Presentation(s):

• (1551550) PI3K inhibitor-resistant B-cell lymphomas show distinct functional phenotypes characterized by sensitivity to Bcl-2- or proteasome-inhibition

  Friday, October 6, 2023
  8:20 AM – 8:30 AM EDT